Cargando…

IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production

The proinflammatory cytokine TNF-α is highly expressed in patients with acute myeloid leukemia (AML) and has been demonstrated to induce rapid proliferation of leukemic blasts. Thus suppressing the production of TNF-α is important because TNF-α can auto-regulate own expression through activation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Man Sub, Kang, Jeong-Woo, Jeon, Jae-Sik, Kim, Jae Kyung, Kim, Jong Wan, Hong, Jintae, Yoon, Do-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747366/ https://www.ncbi.nlm.nih.gov/pubmed/26516703

Ejemplares similares

IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
por: Kim, Man Sub, et al.
Publicado: (2015)

IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
por: Bak, Yesol, et al.
Publicado: (2016)

Human IL-32θA94V mutant attenuates monocyte-endothelial adhesion by suppressing the expression of ICAM-1 and VCAM-1 via binding to cell surface receptor integrin αVβ3 and αVβ6 in TNF-α-stimulated HUVECs
por: Park, Jae-Young, et al.
Publicado: (2023)

Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity
por: Shim, Saerok, et al.
Publicado: (2022)

Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association
por: Pham, Thu-Huyen, et al.
Publicado: (2019)

Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
por: Pham, Thu-Huyen, et al.
Publicado: (2019)

Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells
por: Pham, Thu-Huyen, et al.
Publicado: (2021)

IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling
por: Yun, Hyung-Mun, et al.
Publicado: (2015)

Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification
por: Park, Yun Sun, et al.
Publicado: (2014)

IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
por: Moon, Young-Mee, et al.
Publicado: (2012)

Circulating IL-32 and IL-33 levels in patients with asthma and COPD: a retrospective cross-sectional study
por: Kim, Min-Hye, et al.
Publicado: (2022)

TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN
por: Qiu, Qiang, et al.
Publicado: (2023)

Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
por: Shin, Ji Eun, et al.
Publicado: (2023)

Black Ginseng Extract Exerts Potentially Anti-Asthmatic Activity by Inhibiting the Protein Kinase Cθ-Mediated IL-4/STAT6 Signaling Pathway
por: Song, Yu Na, et al.
Publicado: (2023)

Identification of Synaptic DGKθ Interactors That Stimulate DGKθ Activity
por: Barber, Casey N., et al.
Publicado: (2022)

IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway
por: Lee, Yong Sun, et al.
Publicado: (2019)

On θ(ω) continuity
por: Al Ghour, Samer, et al.
Publicado: (2020)

IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation
por: Kwon, Kee Woong, et al.
Publicado: (2019)

Improved survival outcomes and restoration of graft‐vs‐leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia
por: Cho, Byung‐Sik, et al.
Publicado: (2019)

Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia Cells
por: Chang, Fengjiao, et al.
Publicado: (2020)

A Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia
por: Kim, Hyun Woo, et al.
Publicado: (2006)

Reclassification of Acute Myeloid Leukemia According to the 2016 WHO Classification
por: Jung, Jin, et al.
Publicado: (2019)

Characteristics of DNMT3A mutations in acute myeloid leukemia
por: Park, Dong Jin, et al.
Publicado: (2020)

Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition
por: Lee, Yong Sun, et al.
Publicado: (2018)

Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 Fusion
por: Yun, Jae Won, et al.
Publicado: (2019)

Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia
por: Yoon, Jae-Ho, et al.
Publicado: (2017)

Machine Learning Predicts 30-Day Outcome among Acute Myeloid Leukemia Patients: A Single-Center, Retrospective, Cohort Study
por: Lee, Howon, et al.
Publicado: (2023)

Structural Characteristics of Seven IL-32 Variants
por: Sohn, Dong Hyun, et al.
Publicado: (2019)

Chronic myeloid leukemia with extreme thrombocytosis
por: Kim, So Young, et al.
Publicado: (2012)

Impaired Expression of MAPK Is Associated with the Downregulation of TNF-α, IL-6, and IL-10 in Mycobacterium abscessus Lung Disease
por: Sim, Yun Su, et al.
Publicado: (2012)

IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells
por: Lee, Siyoung, et al.
Publicado: (2017)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

DNA polymerase θ-mediated repair of high LET radiation-induced complex DNA double-strand breaks
por: Yi, Geunil, et al.
Publicado: (2023)

PKCθ Regulates T-Cell Leukemia-Initiating Activity via Reactive Oxygen Species
por: Giambra, Vincenzo, et al.
Publicado: (2012)

Implications of the 5(th) Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia
por: Lee, Cheonghwa, et al.
Publicado: (2023)

IDH1/2 mutations in acute myeloid leukemia
por: Byun, Ja Min, et al.
Publicado: (2022)

Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types
por: Yoon, Jae-Ho, et al.
Publicado: (2017)

New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020)

Targeting ERRα promotes cytotoxic effects against acute myeloid leukemia through suppressing mitochondrial oxidative phosphorylation
por: Seo, Wonhyoung, et al.
Publicado: (2022)

Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity
por: Anel, Alberto, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1mlvjiutbtaaem6pbvin70nec6